FDA Advisers Endorse Merck’s COVID Antiviral Drug In Narrow Vote

1 Miami

Miami News & Search

1 News - 1 eMovies - 1 eMusic - 1 eBooks - 1 Search

A panel of the Food and Drug Administration’s outside drug advisers voted narrowly Tuesday to back allowing Ridgeback Biotherapeutics and Merck’s antiviral pills to be prescribed for COVID-19, following an hours-long meeting mulling the benefits and risks of molnupiravir to treat the disease in high-risk adults.

1 Miami

Miami News & Search

1 News - 1 eMovies - 1 eMusic - 1 eBooks - 1 Search